| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.6 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.1 | 0.1 |